Unique Ingredient Identifier 0RE8K4LNJS is listed as a ingredient substance
RN | 110-27-0 |
EC | 203-751-4 |
NCIT | C76717 |
RXCUI | 27985 |
PUBCHEM | 8042 |
MF | C17H34O2 |
INCHI KEY | AXISYYRBXTVTFY-UHFFFAOYSA-N |
SMILES | CCCCCCCCCCCCCC(=O)OC(C)C |
UNII 0RE8K4LNJS ISOPROPYL MYRISTATE is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
AURICULAR (OTIC) | OIL | 3.85 %V/V |
AURICULAR (OTIC) | SUSPENSION | 0.024 % |
TOPICAL | AEROSOL | 9.3 %W/W |
TOPICAL | AEROSOL, SPRAY | NA |
TOPICAL | CREAM | 10 %W/W |
TOPICAL | CREAM, AUGMENTED | 8 %W/W |
TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 10 %W/W |
TOPICAL | EMULSION, AEROSOL FOAM | 7.9 %W/W |
TOPICAL | EMULSION, CREAM | 15 %W/W |
TOPICAL | EMULSION, LOTION | 1 %W/W |
TOPICAL | GEL | 10 %W/W |
TOPICAL | LOTION | 5 %W/W |
TOPICAL | OIL | 13.5 %W/W |
TOPICAL | OIL | 3.55 %W/W |
TOPICAL | OINTMENT | 35 %W/W |
TOPICAL | PATCH, CONTROLLED RELEASE | NA |
TOPICAL | SPRAY | 50.3 %W/W |
TRANSDERMAL | FILM | 58.08 MG |
TRANSDERMAL | FILM, CONTROLLED RELEASE | 20.4 MG |
TRANSDERMAL | GEL | 1 %W/W |
TRANSDERMAL | GEL, METERED | 1 % |
VAGINAL | CREAM, EMULSION, SUPPOSITORY | NA |
VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 1 % |
VAGINAL | EMULSION, CREAM | 1 % |
VAGINAL | SUPPOSITORY, INSERT | 1 %W/W |